Welcome to LookChem.com Sign In|Join Free

CAS

  • or

327-57-1

Post Buying Request

327-57-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

327-57-1 Usage

Description

Alpha-Aminocaproic acid, also known as ε-aminocaproic acid or ACA, is a non-essential amino acid that plays a crucial role in various biological processes. It is a naturally occurring compound found in various foods and is also synthesized in the human body. Its molecular structure consists of a central carbon atom bonded to an amino group, a carboxyl group, and two methyl groups. Due to its unique properties, alpha-aminocaproic acid has found applications in various industries, including pharmaceutical, medical, and analytical chemistry.

Uses

Used in Pharmaceutical Industry:
Alpha-aminocaproic acid is used as an active pharmaceutical ingredient for the treatment of various medical conditions. It is primarily used as an antithrombotic agent, which helps in preventing blood clots and reducing the risk of stroke, heart attack, and other cardiovascular events. It works by inhibiting the activity of plasmin, an enzyme responsible for breaking down blood clots, thus preventing excessive bleeding and clot formation.
Used in Medical Industry:
In the medical field, alpha-aminocaproic acid is used as a hemostatic agent to control bleeding during surgery or in cases of trauma. It is particularly useful in patients with bleeding disorders or those taking anticoagulant medications. By stabilizing the clotting process, it helps in reducing blood loss and promoting faster healing.
Used in Analytical Chemistry:
Alpha-aminocaproic acid is used as an internal standard in amino acid analysis. It serves as a reference compound to ensure the accuracy and reproducibility of the analysis. Its non-essential nature and stable chemical properties make it an ideal candidate for this application.

Biochem/physiol Actions

L-Norleucine is a synthetic amino acid commonly used as an internal standard.

Check Digit Verification of cas no

The CAS Registry Mumber 327-57-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,2 and 7 respectively; the second part has 2 digits, 5 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 327-57:
(5*3)+(4*2)+(3*7)+(2*5)+(1*7)=61
61 % 10 = 1
So 327-57-1 is a valid CAS Registry Number.
InChI:InChI=1/C6H13NO2/c1-2-3-4-5(7)6(8)9/h5H,2-4,7H2,1H3,(H,8,9)/t5-/m0/s1

327-57-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (N0303)  L-Norleucine  >99.0%(T)

  • 327-57-1

  • 100mg

  • 110.00CNY

  • Detail
  • TCI America

  • (N0303)  L-Norleucine  >99.0%(T)

  • 327-57-1

  • 1g

  • 350.00CNY

  • Detail
  • TCI America

  • (N0303)  L-Norleucine  >99.0%(T)

  • 327-57-1

  • 5g

  • 1,250.00CNY

  • Detail
  • Alfa Aesar

  • (L03913)  L-(+)-Norleucine, 99%   

  • 327-57-1

  • 1g

  • 351.0CNY

  • Detail
  • Alfa Aesar

  • (L03913)  L-(+)-Norleucine, 99%   

  • 327-57-1

  • 5g

  • 1544.0CNY

  • Detail
  • Alfa Aesar

  • (L03913)  L-(+)-Norleucine, 99%   

  • 327-57-1

  • 25g

  • 5896.0CNY

  • Detail
  • Sigma

  • (N6877)  L-Norleucine  ≥98% (TLC)

  • 327-57-1

  • N6877-1G

  • 511.29CNY

  • Detail
  • Sigma

  • (N6877)  L-Norleucine  ≥98% (TLC)

  • 327-57-1

  • N6877-5G

  • 1,584.18CNY

  • Detail
  • Sigma

  • (N6877)  L-Norleucine  ≥98% (TLC)

  • 327-57-1

  • N6877-10G

  • 3,298.23CNY

  • Detail

327-57-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 11, 2017

Revision Date: Aug 11, 2017

1.Identification

1.1 GHS Product identifier

Product name Hexanoic acid, 2-amino-, (S)-

1.2 Other means of identification

Product number -
Other names L-norleucine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:327-57-1 SDS

327-57-1Relevant articles and documents

Enantioselective biocatalytic formal α-amination of hexanoic acid to l-norleucine

Dennig, Alexander,Gandomkar, Somayyeh,Cigan, Emmanuel,Reiter, Tamara C.,Haas, Thomas,Hall, Mélanie,Faber, Kurt

, p. 8030 - 8033 (2018)

A three-step one-pot biocatalytic cascade was designed for the enantioselective formal α-amination of hexanoic acid to l-norleucine. Regioselective hydroxylation by P450CLA peroxygenase to 2-hydroxyhexanoic acid was followed by oxidation to the ketoacid by two stereocomplementary dehydrogenases. Combination with final stereoselective reductive amination by amino acid dehydrogenase furnished l-norleucine in >97% ee.

2(S)-Aminohex-5-ynoic acid, an antimetabolite from Cortinarius claricolor var. Tenuipes

Aoyagi, Yasuo,Sugahara, Tatsuyuki

, p. 1835 - 1836 (1985)

Screening for antimetabolites in edible mushrooms showed that the hot water extract of fruiting bodies of Cortinarius claricolor var. tenuipes strongly inhibited the growth of Bacillus subtilis B-50 in a chemically defined minimal medium. 2(S)-Aminohex-5-ynoic acid was isolated as an active compound.

Semi-rational hinge engineering: modulating the conformational transformation of glutamate dehydrogenase for enhanced reductive amination activity towards non-natural substrates

Liu, Yayun,Meng, Lijun,Wu, Jianping,Yang, Lirong,Yin, Xinjian,Zhou, Haisheng

, p. 3376 - 3386 (2020/06/09)

The active site is the common hotspot for rational and semi-rational enzyme activity engineering. However, the active site represents only a small portion of the whole enzyme. Identifying more hotspots other than the active site for enzyme activity engineering should aid in the development of biocatalysts with better catalytic performance. Glutamate dehydrogenases (GluDHs) are promising and environmentally benign biocatalysts for the synthesis of valuable chirall-amino acids by asymmetric reductive amination of α-keto acids. GluDHs contain an inter-domain hinge structure that facilitates dynamic reorientations of the domains relative to each other. Such hinge-bending conformational motions of GluDHs play an important role in regulating the catalytic activity. Thus, the hinge region represents a potential hotspot for catalytic activity engineering for GluDHs. Herein, we report semi-rational activity engineering of GluDHs with the hinge region as the hotspot. Mutants exhibiting significantly improved catalytic activity toward several non-natural substrates were identified and the highest activity increase reached 104-fold. Molecular dynamics simulations revealed that enhanced catalytic activity may arise from improving the open/closed conformational transformation efficiency of the protein with hinge engineering. In the batch production of three valuablel-amino acids, the mutants exhibited significantly improved catalytic efficiency, highlighting their industrial potential. Moreover, the catalytic activity of several active site tailored GluDHs was also increased by hinge engineering, indicating that hinge and active site engineering are compatible. The results show that the hinge region is a promising hotspot for activity engineering of GluDHs and provides a potent alternative for developing high-performance biocatalysts toward chirall-amino acid production.

Preparative Asymmetric Synthesis of Canonical and Non-canonical a-amino Acids through Formal Enantioselective Biocatalytic Amination of Carboxylic Acids

Dennig, Alexander,Blaschke, Fabio,Gandomkar, Somayyeh,Tassano, Erika,Nidetzky, Bernd

, p. 1348 - 1358 (2019/10/28)

Chemical and biocatalytic synthesis of non-canonical a-amino acids (ncAAs) from renewable feedstocks and using mild reaction conditions has not efficiently been solved. Here, we show the development of a three-step, scalable and modular one-pot biocascade for linear conversion of renewable fatty acids (FAs) into enantiopure l-a-amino acids. In module 1, selective a-hydroxylation of FAs is catalyzed by the P450 peroxygenase P450CLA. By using an automated H2O2 supplementation system, efficient conversion (46 to >99%; TTN>3300) of a broad range of FAs (C6:0 to C16:0) into valuable a-hydroxy acids (a-HAs; >90% a-selective) is shown on preparative scale (up to 2.3 gL1 isolated product). In module 2, a redox-neutral hydrogen borrowing cascade (alcohol dehydrogenase/amino acid dehydrogenase) allowed further conversion of a-HAs into l-a-AAs (20 to 99%). Enantiopure l-a-AAs (e.e. >99%) including the pharma synthon l-homo-phenylalanine can be obtained at product titers of up to 2.5 gL1. Based on renewables and excellent atom economy, this biocascade is among the shortest and greenest synthetic routes to structurally diverse and industrially relevant ncAAs.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 327-57-1